Business Value: exagen.com (XGN)

Brandmark of exagen.com (XGN)

Exagen Inc. (XGN) protects its developments with patents, although competition in diagnostics is gradually lowering market barriers. The company is implementing an eco-friendly approach by minimizing paper documentation and optimizing waste recycling. The company's price evolution on the GURU.Markets platform shows that the Enterprise Value is 206.56. The business relies on the development of the AVISE system, which helps rheumatologists select personalized treatments for autoimmune pathologies to accelerate patient recovery.

XGN Exagen Enterprise Value (11/23/2025 - 10/29/2026)

Exagen (XGN) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Rate Chart Exagen Inc|XGN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Exagen Inc.|XGN - Total Company Value
- balance sheet net asset value indicators:
Accounting Value per Share Exagen Inc.|XGN - Book Capitalization|Market-to-Book Ratio exagen.com|XGN - Company Total Assets
- debt level and financial liquidity data:
Debt to Equity Ratio Exagen Inc.|XGN - Long-Term Debt to Capital|Short-Term Debt to Capital Exagen Inc|XGN - Company Debts|Debt to Book Value Ratio Exagen Inc.|XGN - Company Long-Term Debts|Company Short-Term Debts Exagen Inc.|Quick Liquidity exagen.com
- earnings and multiples data:
XGN - Net Income
Analysis of all company metrics:Exagen Inc. - XGN
Flagship merchandise of Exagen

Rising demand for AVISE diagnostics and the expansion of insurance coverage directly impact the fundamental business value displayed on the GURU.Markets platform. This indicator aggregates market capitalization with total debt minus liquid assets, determining the real acquisition price of Exagen Inc. (XGN) and allowing investors to assess the company's true financial burden during its scaling phase.

Who Exagen Inc. competes with

Full Takeover Company Value Agilent Technologies, Inc.|DGX - Total Company Value|ILMN (Illumina Platform) - Business Value|Exact Sciences (EXAS) - Total Company Value|Real Price to Acquire Entire Company revvity.com|BIO (Bio-Rad) - Enterprise Value|Total Enterprise Value Anbio Biotechnology Ltd NNNN|Enterprise Value SHC|QuidelOrtho Inc. - Business Value|Enterprise Value OPK (OPKO Health, Inc.)|Enterprise Value CareDx Health CDNA|MRVI - Total Company Value|FLGT (Fulgent Genetics Inc) - Business Value|LAB: Enterprise Value|Cytek Corp (CTKB) - Enterprise Value|Total Company Value OraSure Technologies|Total Company Value MDXH|Real Price to Acquire Entire Company LUCD (Lucid Diagnostics)|PRE - Total Enterprise Value|Total Company Value Insight Molecular Diagnostics Inc IMDX|Company Buyout Price Trinity Biotech PLC (TRIB)|ProPhase Labs, Inc. - Enterprise Value|Company Buyout Price ainos.com AIMD|Co-Diagnostics (CODX) - Total Company Value|HSCS - Company Buyout Price|BMRA (Biomerica, Inc) - Enterprise Value|Total Enterprise Value Cardio Diagnostics Holdings, Inc. CDIO|Real Price to Acquire Entire Company VRAX (Virax Biolabs Group)|bluejaydx.com - Business Value|Enterprise Value AWH (Aspira Women's Health Inc.)|Enterprise Value Accelerate Diagnostics Inc. AXDX|Centogene - Enterprise Value|Full Takeover Company Value Enzo Biochem, Inc. (ENZ)|FRES: Enterprise Value|Total Enterprise Value Genetic Technologies Limited (GENE)|Total Company Value 23andMe|Business Value PMD (Psychemedics Corp.)